SENTI
Live / Registered — Registered (as of 10 Sept 2024)
What this means for you
Registered since 10 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97006723
- Registration number
- 7502837
- Mark type
- Stylized text
- Filed
- 01 Sept 2021
- Published for opposition
- 10 Jan 2023
- Registered
- 10 Sept 2024
- Attorney of record
- Nicole Kinsley, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use; genetic material for medical or clinical use; house mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treating diseases through cell therapy and gene therapy
Owner
- Senti Biosciences, Inc., South San Francisco, CA, US
- Senti Biosciences, Inc., South San Francisco, CA, US
- Senti Biosciences, Inc., South San Francisco, CA, US
Prosecution history
- 10 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 05 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jun 2024 — USE AMENDMENT FILED
- 12 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jun 2024 — TEAS STATEMENT OF USE RECEIVED
- 07 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2024 — SOU EXTENSION 2 GRANTED
- 06 Mar 2024 — SOU EXTENSION 2 FILED
- 06 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 05 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Sept 2023 — SOU EXTENSION 1 GRANTED
- 01 Sept 2023 — SOU EXTENSION 1 FILED